Inhibitors | Comment | Organism | Structure |
---|---|---|---|
TT30 | therapeutic fusion protein linking the human complement receptor type 2 C3 fragment-binding domain with the CAP inhibitory domain of human factor H. TT30 efficiently blocks ex vivo CAP-dependent accumulation of C3-fragment on activated surfaces, membrane attack complex formation and hemolysis of red blood cells, without interference of C3 activation or membrane attack complex formation | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |